Photo Gallery

Login

Search

News & Updation

  • WJPPS NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2017 Issue has been successfully launched on 1 November 2017

  • ICV
  • WJPPS Rank with Index Copernicus Value 52.51 due to high reputation at International Level

  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from 6.041 to 6.647 due to high quality Publication at International Level

  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  

Abstract

IN-VITRO EVALUATION OF ANTI-UROLITHIASIS POTENTIAL OF KARUVANGA CHENDOORUM BY STRUVITE CRYSTAL GROWTH INHIBITION ASSAY

K. Anbarasan*, C. Sasikala, D. Sivaraman and P. Shanmugapriya

ABSTRACT

Urolithiasis is a kind of metabolic disorder were individual’s biological system is unable to maintain the calcium hemostasis which was characterized by the formation of stone in the kidney, bladder or urethra. Still, now there is no proper treatment available for clinical management of this condition and there are no proper drugs available in modern medicine that can correct the altered physiology of hemostasis. Siddha system of medicine comprises of natural remedy with therapeutic effects that can dissipate and remove even the larger stones would eliminate the need for a surgery and the risks associated with it. Karuvanga chendoorum (KC) is one such novel Siddha formulation presently used for the treatment of Pramiyam(syphilis), Perumpadu (leucorrhea) and Neerizhivu (diabetic). The main aim of the present investigation is to carry out the anti-urolithiasis activity of the formulation KC by struvite crystal growth inhibition assay at two dose level of 0.5% and 1%. The efficacy of the KC was evaluated by comparing the crystal size of treated medium with that of the control. The average size of the crystal was higher in the control medium with the length of 1.44 ± 0.08 cm and the size of the crystal was significantly decreased in medium contains 0.5% and 1% of test drug KC with the average length of 0.98 ± 0.13 and 0.58 ± 0.17 cm. From the result of the study, it was concluded that the test drug KC has Promising anti-urolithiasis property in the tested medium.

Keywords: Urolithiasis, Siddha system, Karuvanga chendoorum, Struvite crystal, Kidney, Calcium hemostasis.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More